Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-30 08:30 am Purchase |
2021-08-27 | 13G | PharmaCyte Biotech, Inc. PMCB |
SABBY MANAGEMENT LLC | 1,246,245 11.000% |
1,246,245 (New Position) |
Filing History |
| 2021-08-30 06:31 am Purchase |
2021-08-19 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 1,063,210 6.300% |
1,063,210 (New Position) |
Filing History |
| 2020-07-29 4:34 pm Sale |
2020-06-19 | 13D | PharmaCyte Biotech, Inc. PMCB |
Montazeri Nima | 0 0.000% |
-61,459 (Position Closed) |
Filing History |
| 2020-05-06 2:19 pm Purchase |
2019-11-27 | 13D | PharmaCyte Biotech, Inc. PMCB |
Montazeri Nima | 61,459 5.800% |
61,459 (New Position) |
Filing History |